The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation.
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.
TNF blockers may increase the risk of malignancy in children
- Login or register to post comments
- Feed: Pediatrics News Feed
- Original article